The Lancet Oncology: Proton beam therapy offers potential to treat childhood brain cancer with fewer severe side effects than conventional radiotherapy

(The Lancet) Proton beam therapy -- a more precise form of radiotherapy -- to treat the childhood brain cancer medulloblastoma appears to be as safe as conventional radiotherapy with similar survival rates, according to new research published in The Lancet Oncology journal today. Importantly, the findings suggest that proton radiotherapy may not be as toxic to the rest of a child's body as conventional radiotherapy. The study was led by Dr. Torunn Yock, Massachusetts General Hospital, Proton Cen...